• Pediatric Hematology/Oncology Leadership

    Vijay G. Sankaran, MD, PhD

    Vijay G. Sankaran, MD, PhD

    Interim Chief, Division of Hematology/Oncology, Boston Children’s Hospital
    Institute Physician
    Associate Professor of Pediatrics, Harvard Medical School

    Dr. Vijay Sankaran is a physician-scientist focused on caring for patients with non-malignant hematologic disorders with a special interest in diseases of blood cell production and the hemoglobin disorders, including sickle cell disease and thalassemia. He earned his medical degree and PhD from Harvard Medical School. After internship and residency training with the Boston Combined Residency Program, he completed a hematology/oncology fellowship at Dana-Farber/Boston Children’s. The major focus of his career has been on delineating how human genetic variation impacts hematopoiesis in health and disease, as well as how these insights can inform the development of new therapeutic approaches for children with blood disorders.

    David Williams, MD

    David Williams, MD

    President, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Senior Vice President and Chief Scientific Officer, Boston Children's Hospital
    Chief, Division of Hematology/Oncology, Boston Children’s Hospital*
    Institute Physician
    Leland Fikes Professor of Pediatrics, Harvard Medical School

    Dr. David A. Williams is a graduate of Indiana State University and Indiana University School of Medicine. After training in Pediatrics at Cincinnati Children's Hospital Medical Center, Dr. Williams completed fellowship training in Pediatric Hematology/Oncology at Dana-Farber/Boston Children's. He completed his research training here and at the Whitehead Institute at the Massachusetts Institute of Technology. He then became a faculty member at Harvard Medical School and of the Howard Hughes Medical Institute (HHMI).

    *On leave from September 19, 2019 – August 20, 2020

    Scott A. Armstrong, MD, PhD

    Dr. Scott ArmstrongDepartment Chair, Pediatric Oncology, Dana-Farber Cancer Institute
    Associate Chief, Division of Hematology/Oncology, Boston Children’s Hospital
    David G. Nathan Professor of Pediatrics, Harvard Medical School

    Dr. Scott A. Armstrong earned his medical degree and PhD from University of Texas Southwestern Medical School in 1996. After internship and residency training with the Boston Combined Residency Program (BCRP), he completed a hematology/oncology fellowship at Dana-Farber/Boston Children’s. Subsequently, he completed his research training here with Dr. Stanley Korsmeyer. He is a Professor of Pediatrics at Harvard Medical School. The major focus of his career has been delineating the biology of childhood cancers and the development of new therapeutic approaches for children with cancer.

    Lisa Diller, MD

    Lisa Diller, MDChief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Vice Chair, Clinical Affairs
    Medical Director, Clinical Cancer and Blood Disorders Service Line
    Medical Director, David B. Perini, Jr. Quality of Life Clinic
    Institute Physician
    Professor of Pediatrics, Harvard Medical School

    Dr. Lisa Diller leads the joint clinical Pediatric Oncology Program at Dana-Farber/Boston Children's. She is also the Director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelor's degree from Harvard University and earned her medical degree from the University of California at San Diego.

  • Contact Us

    Our specialized new patient coordinators can answer your questions about treatment options and becoming a patient.
  • Find Clinical Trials

    We sponsor and collaborate on clinical trials that break new ground in pediatric cancer and blood disorder treatment. callout bg
  • Ranked #1 for Cancer Care

    U.S. News Best Children's Hospitals logoU.S. News & World Report ranked Dana-Farber/Boston Children's the #1 pediatric cancer hospital in the nation.